First published on 06 Dec 2019
Consensus statements for management of Barrett’s dysplasia and early-stage oesophageal adenocarcinoma
NICE has accredited the process used by the BAD CAT (BArrett’s Dysplasia and CAncer Taskforce) consensus group to produce its guidelines using consensus statements for management of Barrett’s dysplasia and early-stage oesophageal adenocarcinoma. Accreditation is valid for 5 years from September 2012 and […]